A specific pattern of gray matter atrophy in Alzheimer’s disease with depression
暂无分享,去创建一个
A. Papanicolaou | I. Seimenis | S. Papageorgiou | E. Karavasilis | J. Papatriantafyllou | T. Parthimos | George Kapsas
[1] Wiro J. Niessen,et al. Fine-mapping the effects of Alzheimer's disease risk loci on brain morphology , 2016, Neurobiology of Aging.
[2] J. E. Park,et al. Voxel-based lesion symptom mapping analysis of depressive mood in patients with isolated cerebellar stroke: A pilot study , 2016, NeuroImage: Clinical.
[3] K. Jellinger,et al. Vascular depression consensus report – a critical update , 2016, BMC Medicine.
[4] Timothy S. Coalson,et al. The Human Connectome Project's neuroimaging approach , 2016, Nature Neuroscience.
[5] Xiaozheng Liu,et al. Abnormal degree centrality in Alzheimer's disease patients with depression: A resting-state functional magnetic resonance imaging study , 2016, Experimental Gerontology.
[6] Q. Gong,et al. Brain gray matter alterations in first episodes of depression: A meta-analysis of whole-brain studies , 2016, Neuroscience & Biobehavioral Reviews.
[7] T. Lai,et al. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. , 2016, Journal of affective disorders.
[8] Geraldo F. Busatto,et al. Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment , 2015, PloS one.
[9] D. Blumberger,et al. A Review of Brain Stimulation Treatments for Late-Life Depression , 2015, Current Treatment Options in Psychiatry.
[10] L. Palaniyappan,et al. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. , 2015, World journal of psychiatry.
[11] J. Raduà,et al. Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease , 2015, Translational Neurodegeneration.
[12] John-Paul Taylor,et al. Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? , 2014, Alzheimer's Research & Therapy.
[13] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[14] W. Taylor,et al. The vascular depression hypothesis: mechanisms linking vascular disease with depression , 2013, Molecular Psychiatry.
[15] B. Kee,et al. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease , 2013, Neuroscience Letters.
[16] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[17] O. Abe,et al. Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra provides reduced effect of scanner for cortex volumetry with atlas-based method in healthy subjects , 2013, Neuroradiology.
[18] Y. Gustafson,et al. Usefulness of the Geriatric Depression Scale 15-item version among very old people with and without cognitive impairment , 2013, Aging & mental health.
[19] Vijay K. Venkatraman,et al. Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[20] Klaus P. Ebmeier,et al. Magnetic resonance imaging in late-life depression: vascular and glucocorticoid cascade hypotheses , 2012, British Journal of Psychiatry.
[21] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[22] Mark Jenkinson,et al. Structural MRI changes detectable up to ten years before clinical Alzheimer's disease , 2012, Neurobiology of Aging.
[23] C. Bottino,et al. Effect of temporal lobe structure volume on memory in elderly depressed patients , 2011, Neurobiology of Aging.
[24] G. Busatto,et al. Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies , 2011, Neurobiology of Aging.
[25] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[26] Paul E. Croarkin,et al. Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[27] G. Kiosseoglou,et al. Adaptation of Addenbrooke’s Cognitive Examination‐Revised for the Greek population , 2011, European journal of neurology.
[28] J. Rabey,et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study , 2011, Journal of Neural Transmission.
[29] Sébastien Ourselin,et al. Head size, age and gender adjustment in MRI studies: a necessary nuisance? , 2010, NeuroImage.
[30] F. Agosta,et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease , 2010, Neurology.
[31] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[32] R. Canbeyli. Sensorimotor modulation of mood and depression: An integrative review , 2010, Behavioural Brain Research.
[33] C. Lange,et al. Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. , 2009, Journal of affective disorders.
[34] C. Jack,et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.
[35] Wouter Hulstijn,et al. Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool. , 2008, Journal of affective disorders.
[36] Clifford R. Jack,et al. Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.
[37] Joost Janssen,et al. Cerebral volume measurements and subcortical white matter lesions and short‐term treatment response in late life depression , 2007, International journal of geriatric psychiatry.
[38] John R Hodges,et al. The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.
[39] Faith M. Gunning-Dixon,et al. Structural neuroimaging research methods in geriatric depression. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[40] François Mauguière,et al. Experiencing and detecting happiness in humans: The role of the supplementary motor area , 2006, Annals of neurology.
[41] Arthur W Toga,et al. Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods. , 2004, The American journal of psychiatry.
[42] R Rigolino,et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[43] Joseph A Maldjian,et al. Precentral gyrus discrepancy in electronic versions of the Talairach atlas , 2004, NeuroImage.
[44] Paul J. Laurienti,et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.
[45] F. Dick,et al. Voxel-based lesion–symptom mapping , 2003, Nature Neuroscience.
[46] Emma J. Burton,et al. A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.
[47] C. Lyketsos,et al. Depression in Alzheimer’s disease: overview and treatment , 2002, Biological Psychiatry.
[48] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[49] Nick C Fox,et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.
[50] I Litvan,et al. The FAB: A frontal assessment battery at bedside , 2000, Neurology.
[51] H. Braak,et al. Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer? , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[52] M Ashtari,et al. Hippocampal/amygdala volumes in geriatric depression , 1999, Psychological Medicine.
[53] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[54] Nick C Fox,et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.
[55] M. Mulvihill,et al. Validating the GDS Depression Screen in the Nursing Home , 1994, Journal of the American Geriatrics Society.
[56] W. Burke,et al. A Prospective Evaluation of the Geriatric Depression Scale in an Outpatient Geriatric Assessment Center , 1992, Journal of the American Geriatrics Society.
[57] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[58] L. Piccardi,et al. Neuroanatomy of Alzheimer's Disease and Late-Life Depression: A Coordinate-Based Meta-Analysis of MRI Studies. , 2015, Journal of Alzheimer's disease : JAD.
[59] Wei Chen,et al. Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study. , 2015, Journal of Alzheimer's disease : JAD.
[60] P. Modrego. Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment. , 2010, Journal of Alzheimer's disease : JAD.
[61] A. Leventhal,et al. The empirical status of melancholia: implications for psychology. , 2005, Clinical psychology review.
[62] L. Gibbons,et al. Quality of life in Alzheimer's disease: Patient and caregiver reports. , 1999 .
[63] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[64] W. Zung. A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.